NASDAQ:GNOM - Complete Genomics Stock Price, Price Target & More

$3.14 0.00 (0.00 %)

(As of 04/23/2018 02:01 AM ET)

Previous Close$3.14

Today's RangeN/A

52-Week Range$1.57 - $3.50

VolumeN/A

Average Volume133,057 shs

Market Capitalization$108.29 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

About Complete Genomics (NASDAQ:GNOM)

Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.

Receive GNOM News and Ratings via Email

Sign-up to receive the latest news and ratings for GNOM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A

Sub-IndustryN/A

SectorN/A

SymbolNASDAQ:GNOM

CUSIPN/A

Webwww.completegenomics.com

Phone+1-650-9432800

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / CashN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

EmployeesN/A

Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

Complete Genomics (NASDAQ:GNOM) Frequently Asked Questions

What is Complete Genomics' stock symbol?

Complete Genomics trades on the NASDAQ under the ticker symbol "GNOM."

Who are some of Complete Genomics' key competitors?

Some companies that are related to Complete Genomics include Fortress Biotech (FBIO), Orrstown Financial Services (ORRF), Verastem (VSTM), Consolidated Water (CWCO), Riverview Bancorp (RVSB), Sportsman's Warehouse (SPWH), Veracyte (VCYT), EXFO (EXFO), FS Bancorp (FSBW), Tocagen (TOCA), Ceragon (CRNT), NTELOS (NTLS), Hallador Energy (HNRG), Rightside Group (NAME), Compugen (CGEN), Maxwell Technologies (MXWL), Harvard Bioscience (HBIO) and Monarch Financial (MNRK).

Has Complete Genomics been receiving favorable news coverage?

News headlines about GNOM stock have trended somewhat positive on Monday, Accern Sentiment Analysis reports. Accern ranks the sentiment of press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Complete Genomics earned a news impact score of 0.12 on Accern's scale. They also assigned news articles about the company an impact score of 46.59 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.

How do I buy shares of Complete Genomics?

Shares of GNOM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Complete Genomics' stock price today?

One share of GNOM stock can currently be purchased for approximately $3.14.

How big of a company is Complete Genomics?

Complete Genomics has a market capitalization of $108.29 million.

How can I contact Complete Genomics?

Complete Genomics' mailing address is 2071 Stierlin Ct, MOUNTAIN VIEW, CA 94043-4655, United States. The company can be reached via phone at +1-650-9432800.

MarketBeat Community Rating for Complete Genomics (GNOM)

Community Ranking:		2.4 out of 5 ( )
Outperform Votes:		117 (Vote Outperform)
Underperform Votes:		130 (Vote Underperform)
Total Votes:		247

MarketBeat's community ratings are surveys of what our community members think about Complete Genomics and other stocks. Vote "Outperform" if you believe GNOM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNOM will underperform the S&P 500 over the long term. You may vote once every thirty days.

Complete Genomics (NASDAQ:GNOM) Analyst Ratings History

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details

(Data available from 4/23/2016 forward)

Complete Genomics (NASDAQ:GNOM) Earnings History and Estimates Chart

Earnings by Quarter for Complete Genomics (NASDAQ:GNOM)

Complete Genomics (NASDAQ GNOM) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/9/2012	Q312	($0.52)	($0.52)	$8.05 million	$7.27 million	View	N/A
8/8/2012	Q2 2012	($0.58)	($0.51)			View	N/A
5/7/2012	Q1 2012	($0.61)	($0.60)			View	N/A
3/8/2012	Q4 2011	($0.64)	($0.67)			View	N/A
11/7/2011	Q3 2011	($0.55)	($0.65)			View	N/A
8/3/2011	Q2 2011	($0.47)	($0.56)			View	N/A
5/9/2011	Q1 2011	($0.52)	($0.48)			View	N/A
3/10/2011	Q4 2010	($0.65)	($0.69)			View	N/A
12/17/2010	Q3 2010		($12.64)			View	N/A

(Earnings results data provided by Zacks Investment Research)

Complete Genomics (NASDAQ:GNOM) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Complete Genomics (NASDAQ GNOM) Insider Trading and Institutional Ownership History

Insider Trading History for Complete Genomics (NASDAQ:GNOM)

Complete Genomics (NASDAQ GNOM) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details

(Data available from 1/1/2013 forward)

Complete Genomics (NASDAQ GNOM) News Headlines

Source:

Date	Headline
	Comparing Complete Genomics (GNOM) & Allscripts Healthcare Solutions (MDRX) www.americanbankingnews.com - February 28 at 9:16 PM
	Analyzing Complete Genomics (GNOM) & Omnicell (OMCL) www.americanbankingnews.com - February 23 at 4:44 PM
	Complete Genomics (GNOM) vs. Simulations Plus (SLP) Financial Comparison www.americanbankingnews.com - January 23 at 9:28 AM
	Head-To-Head Analysis: Complete Genomics (GNOM) and The Competition www.americanbankingnews.com - January 21 at 9:46 AM
	Financial Contrast: Complete Genomics (GNOM) versus Its Competitors www.americanbankingnews.com - January 20 at 9:14 PM
	Critical Contrast: Complete Genomics (GNOM) & The Competition www.americanbankingnews.com - January 18 at 11:30 PM
	Complete Genomics (GNOM) vs. The Competition Head-To-Head Review www.americanbankingnews.com - January 18 at 1:32 PM
	Complete Genomics (GNOM) vs. Its Peers Critical Analysis www.americanbankingnews.com - January 18 at 7:14 AM
	Head to Head Analysis: NantHealth (NH) vs. Complete Genomics (GNOM) www.americanbankingnews.com - January 18 at 1:10 AM
	Comparing NantHealth (NH) and Complete Genomics (GNOM) www.americanbankingnews.com - January 17 at 9:06 AM
	Comparing Complete Genomics (GNOM) & Its Peers www.americanbankingnews.com - January 17 at 5:14 AM
	Complete Genomics (GNOM) and The Competition Head-To-Head Comparison www.americanbankingnews.com - January 15 at 5:10 PM
	Head to Head Contrast: Complete Genomics (GNOM) and Its Peers www.americanbankingnews.com - January 15 at 5:38 AM
	Complete Genomics (GNOM) vs. Its Rivals Head to Head Review www.americanbankingnews.com - January 14 at 1:08 AM
	Head-To-Head Comparison: Complete Genomics (GNOM) and Its Peers www.americanbankingnews.com - January 14 at 1:08 AM
	Critical Review: Complete Genomics (GNOM) versus Its Competitors www.americanbankingnews.com - January 13 at 11:34 PM
	Complete Genomics (GNOM) vs. The Competition Critical Survey www.americanbankingnews.com - January 12 at 1:06 PM
	Complete Genomics (GNOM) versus The Competition Head to Head Review www.americanbankingnews.com - January 10 at 5:30 PM
	Comparing Complete Genomics (GNOM) & Its Competitors www.americanbankingnews.com - January 10 at 5:10 AM
	Complete Genomics (GNOM) vs. Its Competitors Head-To-Head Comparison www.americanbankingnews.com - January 7 at 11:26 PM
	Head-To-Head Comparison: Complete Genomics (GNOM) vs. The Competition www.americanbankingnews.com - January 6 at 9:12 PM
	Head-To-Head Analysis: Complete Genomics (GNOM) & Its Peers www.americanbankingnews.com - January 6 at 7:14 PM
	Analyzing Complete Genomics (GNOM) and Its Peers www.americanbankingnews.com - January 6 at 7:02 AM
	Critical Analysis: Complete Genomics (GNOM) and Its Rivals www.americanbankingnews.com - January 4 at 7:30 PM
	Contrasting Complete Genomics (GNOM) and Its Competitors www.americanbankingnews.com - January 2 at 12:18 PM
	Complete Genomics (GNOM) versus The Competition Critical Survey www.americanbankingnews.com - January 1 at 11:32 PM
	Contrasting Complete Genomics (GNOM) and Its Peers www.americanbankingnews.com - January 1 at 3:28 AM
	Head-To-Head Analysis: athenahealth (ATHN) & Complete Genomics (GNOM) www.americanbankingnews.com - December 30 at 11:13 AM
	Complete Genomics (GNOM) & Its Competitors Critical Review www.americanbankingnews.com - December 28 at 8:18 AM
	Financial Comparison: Complete Genomics (GNOM) vs. The Competition www.americanbankingnews.com - December 26 at 8:01 PM
	Complete Genomics (GNOM) and Its Rivals Critical Contrast www.americanbankingnews.com - December 26 at 5:24 PM
	Analyzing Complete Genomics (GNOM) & Its Competitors www.americanbankingnews.com - December 26 at 3:28 PM
	Analyzing Complete Genomics (GNOM) and Its Competitors www.americanbankingnews.com - December 26 at 9:24 AM
	Reviewing Complete Genomics (GNOM) & The Competition www.americanbankingnews.com - December 25 at 3:28 AM
	athenahealth (ATHN) vs. Complete Genomics (GNOM) Financial Survey www.americanbankingnews.com - December 24 at 3:30 PM
	Healthequity (HQY) vs. Complete Genomics (GNOM) Head to Head Comparison www.americanbankingnews.com - December 24 at 8:05 AM
	Reviewing Complete Genomics (GNOM) and Its Competitors www.americanbankingnews.com - December 23 at 8:00 AM
	Contrasting Medical Transcription Billing (MTBC) & Complete Genomics (GNOM) www.americanbankingnews.com - December 12 at 11:16 PM
	Castlight Health (CSLT) vs. Complete Genomics (GNOM) Financial Contrast www.americanbankingnews.com - December 5 at 11:26 AM
	Veeva Systems (VEEV) & Complete Genomics (GNOM) Head to Head Analysis www.americanbankingnews.com - November 22 at 9:38 PM
	Reviewing Fluidigm Corporation (FLDM) and Complete Genomics (GNOM) www.americanbankingnews.com - November 6 at 3:15 PM

Complete Genomics (NASDAQ:GNOM) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Complete Genomics (NASDAQ:GNOM) Income Statement, Balance Sheet and Cash Flow Statement

Complete Genomics (NASDAQ GNOM) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff